Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...
PinkDx Publishes Groundbreaking Evidence in Endometrial Cancer Detection Using a Simple Vaginal Swab
Peer-reviewed breakthrough opens the door to a radically less invasive diagnostic pathway for womenSAN FRANCISCO, April 6, ...
April 06, 2026) Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich ...
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...
Caris Life Sciences Inc. CAI shares are up during Wednesday’s premarket session following the announcement of finalized ...
The study included 3,014 patients evaluated based on high-risk screening, symptomatic presentation, or identification of a mass on imaging.
Caris Detect leverages Caris' industry-leading molecular profiling data, which has processed more than 1 million cases and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results